JP2002534393A5 - - Google Patents

Download PDF

Info

Publication number
JP2002534393A5
JP2002534393A5 JP2000592015A JP2000592015A JP2002534393A5 JP 2002534393 A5 JP2002534393 A5 JP 2002534393A5 JP 2000592015 A JP2000592015 A JP 2000592015A JP 2000592015 A JP2000592015 A JP 2000592015A JP 2002534393 A5 JP2002534393 A5 JP 2002534393A5
Authority
JP
Japan
Prior art keywords
growth hormone
transplantation
induces
initiated
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000592015A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002534393A (ja
JP4808316B2 (ja
Filing date
Publication date
Priority claimed from EP98124834A external-priority patent/EP1016413A1/en
Application filed filed Critical
Publication of JP2002534393A publication Critical patent/JP2002534393A/ja
Publication of JP2002534393A5 publication Critical patent/JP2002534393A5/ja
Application granted granted Critical
Publication of JP4808316B2 publication Critical patent/JP4808316B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000592015A 1998-12-30 1999-12-30 多能性造血幹細胞の動員を刺激するためのヒト成長ホルモン Expired - Fee Related JP4808316B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98124834A EP1016413A1 (en) 1998-12-30 1998-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
EP98124834.7 1998-12-30
PCT/EP1999/010470 WO2000040260A1 (en) 1998-12-30 1999-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Publications (3)

Publication Number Publication Date
JP2002534393A JP2002534393A (ja) 2002-10-15
JP2002534393A5 true JP2002534393A5 (https=) 2010-11-18
JP4808316B2 JP4808316B2 (ja) 2011-11-02

Family

ID=8233268

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000592015A Expired - Fee Related JP4808316B2 (ja) 1998-12-30 1999-12-30 多能性造血幹細胞の動員を刺激するためのヒト成長ホルモン

Country Status (15)

Country Link
US (1) US20060029581A1 (https=)
EP (3) EP1016413A1 (https=)
JP (1) JP4808316B2 (https=)
AT (1) ATE342064T1 (https=)
AU (2) AU772222B2 (https=)
BR (1) BR9916726A (https=)
CA (1) CA2354194A1 (https=)
CY (1) CY1107603T1 (https=)
DE (1) DE69933581T2 (https=)
DK (1) DK1140149T3 (https=)
ES (1) ES2275359T3 (https=)
IL (2) IL143994A0 (https=)
PT (1) PT1140149E (https=)
SI (1) SI1140149T1 (https=)
WO (1) WO2000040260A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003535144A (ja) * 2000-06-07 2003-11-25 アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ 多能性造血幹細胞の流動を刺激するヒト成長ホルモン
CA2417356A1 (en) 2000-08-01 2002-02-07 Yissum Research Development Company Directed differentiation of embryonic cells
ES2380009T3 (es) * 2001-07-31 2012-05-07 Genzyme Global S.A.R.L. Métodos para movilizar las células madre/progenitoras
CA2540529C (en) * 2003-10-03 2012-03-13 Vib Vzw Means and methods for the recruitment and identification of stem cells
JP2005289837A (ja) * 2004-03-31 2005-10-20 Juntendo 骨髄細胞誘導剤の製造方法及び製造装置
US7816320B2 (en) * 2004-12-22 2010-10-19 Ambrx, Inc. Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35
JP2013515081A (ja) * 2009-12-21 2013-05-02 アンブルックス,インコーポレイテッド 修飾されているブタのソマトトロピンポリペプチドおよびそれらの使用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5649904A (en) * 1988-10-07 1997-07-22 Sandoz Ltd. Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
EP0563485A1 (en) * 1992-03-30 1993-10-06 Schering-Plough In vitro generation of human dendritic cells and uses thereof
DE69430059T2 (de) * 1993-06-15 2002-11-14 British Biotech Pharmaceuticals Ltd., Cowley Freisetzung und Mobilisierung hämatopoietischer Zellen
JPH07101877A (ja) * 1993-10-04 1995-04-18 Mitsui Toatsu Chem Inc 血小板減少症治療剤
DE69433967D1 (de) * 1993-10-06 2004-09-30 Univ Florida Stammzellen-proliferations-faktor
JPH0892001A (ja) * 1994-09-26 1996-04-09 Asahi Medical Co Ltd 細胞集団の保存方法
EP0871458B1 (en) * 1995-07-21 2002-11-20 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
EP0877795A4 (en) * 1996-01-16 2003-03-05 Depuy Orthopaedics Inc INSULATION OF PROCUREMENT CELLS FROM HEMATOPOIETIC AND NON-HEMATOPOIETIC TISSUES AND THEIR USE
JP4042925B2 (ja) * 1996-11-20 2008-02-06 シスメックス株式会社 幼若白血球の分類計数法
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法
SE9804064D0 (sv) * 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
DE69919969T2 (de) * 1998-12-17 2005-09-29 Applied Research Systems Ars Holding N.V. Humanes Wachstumshormon zur Stimulierung der Hämatopoese und der Immunrekonstitution nach hämatopoetischer Stammzelltransplantation beim Menschen
JP2003535144A (ja) * 2000-06-07 2003-11-25 アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ 多能性造血幹細胞の流動を刺激するヒト成長ホルモン
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Similar Documents

Publication Publication Date Title
Reichenspurner et al. Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis
JP2002529508A5 (ja) 移植における免疫応答抑制のための線維芽細胞または線維芽細胞からの上澄みを含む組成物およびその使用法
DK1808438T3 (da) Rensning og stabilisering af peptid og proteiner i lægemidler
CA2387542A1 (en) Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation
ATE153856T1 (de) Zusammensetzung zur stimulierung des immunsystems
YU18899A (sh) L-nukleozidi purina, njihovi analogoni i primena
CA2208047A1 (en) Increasing creatine and glycogen concentration in muscle
JP2018537472A (ja) 増殖造血幹細胞/前駆細胞集団の利用
Jin et al. 3D printing incorporating gold nanozymes with mesenchymal stem cell-derived hepatic spheroids for acute liver failure treatment
IL153288A0 (en) Use of growth hormone or a derivative thereof in the preparation of a medicament for hematopoiesis
JP2002534393A5 (https=)
KR950700079A (ko) 이식체-대-숙주 질환을 억제하기 위한 인터루킨-10의 용도(Use of interleukin-10 to suppress graft-vs. -host disease)
DE60313356D1 (de) Verwendungvon dextransulfat zur behandlung von ibmir
BR9914644A (pt) Composições tamponadas para diálise
JP2008531696A5 (https=)
Carella et al. Autografting in chronic myeloid leukemia
JP2000178203A5 (https=)
Lindvall et al. First step towards cell therapy for Huntington's disease.
JP2005506959A5 (https=)
WO2008045528A3 (en) Methods and compositions for the treatment of cancer
EP1016414A3 (en) Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans
Borgies et al. Interferon alpha induced and maintained complete remission in chronic granulocytic leukemia in relapse after bone marrow transplantation
Villaron et al. Bone marrow mesenchymal stem cells chimerism after allogeneic hematopoietic transplantation
Wang et al. Omentum transplantation and revascularization
Kalvit De novo histoid leprosy in an immunocompetent male: a rare case report from North east India